Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.3
Journals
IJERPH
Special Issues
Quality of Life and Outcomes of Patients with Urological Diseases
ijerph-logo
Submit to IJERPH Review for IJERPH Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Quality of Life and Outcomes of Patients with Urological Diseases

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601).

Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 6027

Special Issue Editor

Dr. John W. Yuen

E-Mail Website
Guest Editor
School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong, China
Interests: urolithiasis; urological cancer; bladder cancer prophylaxis; quality of life; men’s health; nocturia; disease modeling; pathogenesis; biomarkers

Special Issue Information

Dear Colleagues,

Urological diseases include a wide variety of conditions affecting the urinary tract, including infections, stones and cancers. Due to the anatomical differences between males and females, an estimated 50% of women report having had a urinary tract infection in their lifetime, compared with 15% of men. However, urinary tract infection also contributes to approximately 40% of nosocomial infections, which are mainly caused by urinary catheterization, whereas urolithiasis is mainly associated with lifestyle, affecting 12% of the world population. For both genders, urinary incontinence and nocturia are common signs of many health conditions that may or may not involve urological diseases, and are commonly multifactorial in etiology. Benign prostatic hyperplasia and prostate cancer, along with other prostate gland conditions, are specific to males. The field of urology also deals with erectile dysfunction in males. In the new era of medicine, the emphasis on quality of life and advancements in technology have largely improved the management strategies and outcomes of patients with urological diseases.

In this Special Issue, we focus on the epidemiology and etiology of urological diseases, particularly regarding the link between health, outcomes, and the quality of life of patients with urological diseases.

Dr. John W. Yuen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prevalence
  • incidence
  • factors
  • causes
  • lifestyle
  • prognosis
  • survival
  • quality of life

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Other

11 pages, 2008 KiB  
Article
Posterior Tibial Nerve Stimulation in Children with Lower Urinary Tract Dysfunction: A Mixed-Methods Analysis of Experiences, Quality of Life and Treatment Effect
by Liesbeth L. De Wall, Anna P. Bekker, Loes Oomen, Vera A. C. T. Janssen, Barbara B. M. Kortmann, John P. F. A. Heesakkers and Anke J. M. Oerlemans
Int. J. Environ. Res. Public Health 2022, 19(15), 9062; https://doi.org/10.3390/ijerph19159062 - 25 Jul 2022
Cited by 1 | Viewed by 3267
Abstract
Background: Posterior tibial nerve stimulation (PTNS) is one of the treatment modalities for children with therapy-refractory lower urinary tract dysfunction (LUTD). This study used a mixed-methods analysis to gain insight into the experiences of children treated with PTNS and their parents, the effect [...] Read more.
Background: Posterior tibial nerve stimulation (PTNS) is one of the treatment modalities for children with therapy-refractory lower urinary tract dysfunction (LUTD). This study used a mixed-methods analysis to gain insight into the experiences of children treated with PTNS and their parents, the effect of treatment on quality of life (QOL) and the effect of PTNS on urinary symptoms. Methods: Quantitative outcomes were assessed through a single-centre retrospective chart analysis of all children treated with PTNS in a group setting between 2016–2021. Voiding parameters and QOL scores before and after treatment were compared. Qualitative outcomes were assessed by an explorative study involving semi-structured interviews transcribed verbatim and inductively analysed using the constant-comparative method. Results: The data of 101 children treated with PTNS were analysed. Overall improvement of LUTD was seen in 42% and complete resolution in 10%. Average and maximum voided volumes significantly increased. QOL improved in both parents and children independent of the actual effect on urinary symptoms. Interviews revealed PTNS to be well-tolerated. Facilitating PTNS in a group setting led to feelings of recognition in both children and parents. Conclusions: PTNS is a good treatment in children with therapy-refractory LUTD and provides valuable opportunities for peer support if given in a group setting. Full article
(This article belongs to the Special Issue Quality of Life and Outcomes of Patients with Urological Diseases)
►▼ Show Figures

Figure 1

Other

Jump to: Research

24 pages, 2555 KiB  
Systematic Review
Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review
by John W. Yuen, Ricky W. Wu, Shirley S. Ching and Chi-Fai Ng
Int. J. Environ. Res. Public Health 2022, 19(17), 10825; https://doi.org/10.3390/ijerph191710825 - 30 Aug 2022
Cited by 5 | Viewed by 2213
Abstract
Background: Conventional and newly emerged intravesical modalities have demonstrated prophylactic effectiveness that may improve quality of life (QoL) in non-muscle invasive bladder cancer. The purpose of this study is to analyze existing QoL evidence in patients receiving any form of intravesical therapy. Methods: [...] Read more.
Background: Conventional and newly emerged intravesical modalities have demonstrated prophylactic effectiveness that may improve quality of life (QoL) in non-muscle invasive bladder cancer. The purpose of this study is to analyze existing QoL evidence in patients receiving any form of intravesical therapy. Methods: A PubMed search without time restriction was conducted to identify all relevant studies in accordance with the PICOT question. Additionally, a search was also performed in the Cochrane library database, Internet, and citation. The CONSORT 2010 checklist and STROBE statement checklist were used to evaluate the risk of bias of the included studies. Results: A total of 24 eligible articles were included, which consisted of 11 interventional and 13 observational studies. Intravesical therapy with Bacillus Calmette–Guérin (BCG) or certain chemotherapeutic agents worsens symptom burdens and functional performance during the initial induction phase while continuous improved is observed throughout the maintenance treatment and beyond. Hyperthermia has shown a positive trend in enhancing QoL of patients receiving intravesical chemotherapy, which requires more investigations. However, QoL data were unavailable for other forms of immunotherapy, immune checkpoint inhibitors, electromotive drug administration, and photodynamic therapy. Conclusions: Limited studies suggested the long-term positive impact of intravesical BCG immunotherapy and chemotherapy. However, existing evidence was lacking to clarify the impact of many emerging intravesical therapies that have suggested to be effective and safe, which demands treatment-specific QoL studies. Full article
(This article belongs to the Special Issue Quality of Life and Outcomes of Patients with Urological Diseases)
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop